Ready to optimize your health beyond just testosterone numbers
Receptor binding: Both IGF-1 LR3 and native IGF-1 activate the IGF-1 receptor, but the longer chain structure of LR3 provides reduced IGFBP affinity, potentially allowing superior bioavailability in research models
No Phase 3 clinical trials have been completed
Cardiac functional data demonstrate Glyco Hi hearts exhibit modest decreases, relative to WT, in ejection fraction and fractional shortening
Boronic acid-functionalized core-shell-shell magnetic composite microspheres for the selective enrichment of glycoprotein
First, our findings derive primarily from short-term trials and preclinical models, which may not fully recapitulate human physiological complexity, long-term safety outcomes, or inter-individual variability in clinical populations